SCHEMBL29638591

SCHEMBL29638591

Cc1ccc2c(Nc3cccc(C(F)(F)F)c3)nccc2c1NC(=O)c1cnc2c(N)ncnn12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 12/20 0.49
▸ RAF1 P04049 10/20 0.49
▸ CSF1R P07333 5/20 0.49
▸ DDR1 Q08345 5/20 0.49
▸ DDR2 Q16832 5/20 0.49
▸ LCK P06239 3/20 0.49
▸ KDR P35968 3/20 0.49
▸ TEK Q02763 1/20 0.49
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ ARAF P10398 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ BTK Q06187 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24399601 1.00 BRAF (0.49) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399635 0.88 RAF1 (0.62) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638605 0.88 RAF1 (0.62) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638501 0.84 BRAF (0.52) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25375784 0.84 BRAF (0.52) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399605 0.84 RAF1 (0.63) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638514 0.84 RAF1 (0.63) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL25373039 0.83 RAF1 (0.49) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL29638609 0.83 RAF1 (0.49) BRAFRAF1CSF1RDDR1DDR2
SCHEMBL24399631 0.81 RAF1 (0.64) BRAFRAF1CSF1RDDR1DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 — — WO disclosed
Send feedback